Cargando…

Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase

Traditional medicine and the use of herbal remedies are well established in the African health care system. For instance, Violaceae plants are used for antimicrobial or anti-inflammatory applications in folk medicine. This study describes the phytochemical analysis and bioactivity screening of four...

Descripción completa

Detalles Bibliográficos
Autores principales: Gattringer, Jasmin, Ndogo, Olivier Eteme, Retzl, Bernhard, Ebermann, Carina, Gruber, Christian W., Hellinger, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311463/
https://www.ncbi.nlm.nih.gov/pubmed/34322026
http://dx.doi.org/10.3389/fphar.2021.707596
_version_ 1783728960926908416
author Gattringer, Jasmin
Ndogo, Olivier Eteme
Retzl, Bernhard
Ebermann, Carina
Gruber, Christian W.
Hellinger, Roland
author_facet Gattringer, Jasmin
Ndogo, Olivier Eteme
Retzl, Bernhard
Ebermann, Carina
Gruber, Christian W.
Hellinger, Roland
author_sort Gattringer, Jasmin
collection PubMed
description Traditional medicine and the use of herbal remedies are well established in the African health care system. For instance, Violaceae plants are used for antimicrobial or anti-inflammatory applications in folk medicine. This study describes the phytochemical analysis and bioactivity screening of four species of the violet tribe Allexis found in Cameroon. Allexis cauliflora, Allexis obanensis, Allexis batangae and Allexis zygomorpha were evaluated for the expression of circular peptides (cyclotides) by mass spectrometry. The unique cyclic cystine-rich motif was identified in several peptides of all four species. Knowing that members of this peptide family are protease inhibitors, the plant extracts were evaluated for the inhibition of human prolyl oligopeptidase (POP). Since all four species inhibited POP activity, a bioactivity-guided fractionation approach was performed to isolate peptide inhibitors. These novel cyclotides, alca 1 and alca 2 exhibited IC(50) values of 8.5 and 4.4 µM, respectively. To obtain their amino acid sequence information, combinatorial enzymatic proteolysis was performed. The proteolytic fragments were evaluated in MS/MS fragmentation experiments and the full-length amino acid sequences were obtained by de novo annotation of fragment ions. In summary, this study identified inhibitors of the human protease POP, which is a drug target for inflammatory or neurodegenerative disorders.
format Online
Article
Text
id pubmed-8311463
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-83114632021-07-27 Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase Gattringer, Jasmin Ndogo, Olivier Eteme Retzl, Bernhard Ebermann, Carina Gruber, Christian W. Hellinger, Roland Front Pharmacol Pharmacology Traditional medicine and the use of herbal remedies are well established in the African health care system. For instance, Violaceae plants are used for antimicrobial or anti-inflammatory applications in folk medicine. This study describes the phytochemical analysis and bioactivity screening of four species of the violet tribe Allexis found in Cameroon. Allexis cauliflora, Allexis obanensis, Allexis batangae and Allexis zygomorpha were evaluated for the expression of circular peptides (cyclotides) by mass spectrometry. The unique cyclic cystine-rich motif was identified in several peptides of all four species. Knowing that members of this peptide family are protease inhibitors, the plant extracts were evaluated for the inhibition of human prolyl oligopeptidase (POP). Since all four species inhibited POP activity, a bioactivity-guided fractionation approach was performed to isolate peptide inhibitors. These novel cyclotides, alca 1 and alca 2 exhibited IC(50) values of 8.5 and 4.4 µM, respectively. To obtain their amino acid sequence information, combinatorial enzymatic proteolysis was performed. The proteolytic fragments were evaluated in MS/MS fragmentation experiments and the full-length amino acid sequences were obtained by de novo annotation of fragment ions. In summary, this study identified inhibitors of the human protease POP, which is a drug target for inflammatory or neurodegenerative disorders. Frontiers Media S.A. 2021-07-12 /pmc/articles/PMC8311463/ /pubmed/34322026 http://dx.doi.org/10.3389/fphar.2021.707596 Text en Copyright © 2021 Gattringer, Ndogo, Retzl, Ebermann, Gruber and Hellinger. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Gattringer, Jasmin
Ndogo, Olivier Eteme
Retzl, Bernhard
Ebermann, Carina
Gruber, Christian W.
Hellinger, Roland
Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
title Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
title_full Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
title_fullStr Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
title_full_unstemmed Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
title_short Cyclotides Isolated From Violet Plants of Cameroon Are Inhibitors of Human Prolyl Oligopeptidase
title_sort cyclotides isolated from violet plants of cameroon are inhibitors of human prolyl oligopeptidase
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311463/
https://www.ncbi.nlm.nih.gov/pubmed/34322026
http://dx.doi.org/10.3389/fphar.2021.707596
work_keys_str_mv AT gattringerjasmin cyclotidesisolatedfromvioletplantsofcameroonareinhibitorsofhumanprolyloligopeptidase
AT ndogooliviereteme cyclotidesisolatedfromvioletplantsofcameroonareinhibitorsofhumanprolyloligopeptidase
AT retzlbernhard cyclotidesisolatedfromvioletplantsofcameroonareinhibitorsofhumanprolyloligopeptidase
AT ebermanncarina cyclotidesisolatedfromvioletplantsofcameroonareinhibitorsofhumanprolyloligopeptidase
AT gruberchristianw cyclotidesisolatedfromvioletplantsofcameroonareinhibitorsofhumanprolyloligopeptidase
AT hellingerroland cyclotidesisolatedfromvioletplantsofcameroonareinhibitorsofhumanprolyloligopeptidase